Hematología y Hemoterapia

Resultados: 466
Tipo Título / Nombre Autor(es) Año
A prognostic index for patients with refractory or in first relapsed acute myeloid leukemia treated with FLAG-Ida or Flago-Ida Bergua JM, Montesinos P, Martinez-Cuadrón D, Fernández-Abellán P, Serrano J, Sayas MJ, et al 2014
GEM2005 trial update comparing VMP/VTP as induction in elderly multiple myeloma patients: do we still need alkylators? Mateos MV, Oriol A, Martínez-López J, Teruel AI, López de la Guía A, López J, et al 2014
Observational Prospective Registry for the Assessment of the Clinical Impact of Starting Anti-Myeloma Treatment at Biological Relapse Alegre A, Gironella M, Bergua JM, González E, Esacalante F, Soler A, et al 2014
Treatment of high-risk Philadelphia chromosome-negative acute lymphoblastic leukemia in adolescents and adults according to early cytologic response and minimal residual disease after consolidation assessed by flow cytometry: final results of the PETHEMA Ribera JM, Oriol A, Morgades M, Montesinos P, Sarrà J, González-Campos J, et al 2014
Safety of a new high purity factor X concentrate in the management of hereditary factor X deficiency Norton M, Mitchell WB, Álvarez MT, Austin S, Auerswald G, Bermejo N, et al 2014
Efficacy and safety of a new high purity factor X concentrate in the treatment of severe or moderate factor X deficiency Kavalñ K, Austin S, Álvarez MT, Auerswald G, Bermejo N, Mitchell W [et.al], et al 2014
Pharmacokinetics of a new high purity factor X concentrate in subjects with severe or moderate factor X deficiency Austin S, Álvarez MT, Auerswald G, Bermejo N, Kavakli K, Mitchell W, et al 2014
Relationship Between Extracellular and Intracelular Calcium Mobilization and Platelet Granule Secretion Bermejo N, Berna Erro AR, Redondo Liberal PC, Rosado Dionisio JA, López Nieto E, Salido Ruíz GM, et al 2014
Different Clinical Manifestation of Dysfibrinogenemias Associated to the Mutation Arg275 In Exon 8 of FGG Gene Mesa E, Vila V, Gómez N, Leyva R, Haya S, Cid AR, et al 2014
How we should treat the patients with cryptogenic ischemic stroke or transient ischemic attacks and antiphospholipid syndrome? Bermejo N, Martín Aguilera C, Bañas H, Arcos MJ, Ibañez F, Salgado R, et al 2014